|
|||||
|
|
Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting |
|
| Authors: | Bayle Arnaud Droin N. Besse B. Zou Z. Boursin Y. Rissel S. Solary E. Lacroix L. Rouleau E. Borget I. Bonastre J. |
| Affiliation: | 1.Biostatistics and Epidemiology Unit, Gustave Roussy Cancer Centre, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France ;2.Centre for Research in Epidemiology and Population Health, INSERM U1018, Villejuif, France ;3.UMS CNRS 3655 and INSERM US23, AMMICa, Gustave Roussy, Villejuif, France ;4.Université Paris-Sud, Orsay, France ;5.Digital Transformation and IT System Department, Gustave Roussy Cancer Centre, 94805, Villejuif, France ; |
| Abstract: | The European Journal of Health Economics - Although high-throughput sequencing is revolutionising medicine, data on the actual cost of whole exome sequencing (WES) applications are needed. We aimed... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |